DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis
Public ClinicalTrials.gov record NCT05415722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy as Well as in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis (NASH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2a Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy as well as in Combination with TERN-101 in Noncirrhotic Adults with Presumed Non-Alcoholic Steatohepatitis (NASH)
Study identification
- NCT ID
- NCT05415722
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 162 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 28, 2022 (Actual)
- Primary completion
- Jul 10, 2023 (Actual)
- Completion
- Jul 10, 2023 (Actual)
- Last update posted
- Mar 12, 2025
2022 – 2023
United States locations
- U.S. sites
- 35
- U.S. states
- 12
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 1017: The Institute for Liver Health dba Arizona Liver Health | Chandler | Arizona | 85224 | — |
| Site 1018: Arizona Liver Health | Tucson | Arizona | 85712 | — |
| Site 1004 Southern California Research Center | Coronado | California | 92118 | — |
| Site 1061 Velocity Clinical Research, Gardena | Gardena | California | 90247 | — |
| Site 1013 University of California, San Diego - Altman Clinical and Translational Research Institute | La Jolla | California | 92037 | — |
| Site 1016 Ruane Clinical Research Group Inc. | Los Angeles | California | 90036 | — |
| Site 1060 Catalina Research Institute, LLC | Montclair | California | 91763 | — |
| Site 1001 National Research Institute | Panorama City | California | 91402 | — |
| Site 1040 Inland Empire Clinical Trials, LLC | Rialto | California | 92377 | — |
| Site 1062 Excel Medical Clinical Trials, LLC | Boca Raton | Florida | 33434 | — |
| Site 1057:Integrity Clinical Research, LLC | Doral | Florida | 33122 | — |
| Site 1041: Florida Research Institute | Lakewood Rch | Florida | 34211 | — |
| Site 1058 Optimus U Corporation | Miami | Florida | 33125 | — |
| Site 1036 Schiff Center for Liver Diseases / University of Miami | Miami | Florida | 33136 | — |
| Site 1045 University of Miami Hospital & Clinics, Sylvester Comp. Cancer Center | Miami | Florida | 33136 | — |
| Site 1007: Floridian Clinical Research, LLC | Miami Lakes | Florida | 33016 | — |
| Site 1055: Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Site 1032 IU Health University Hospital | Indianapolis | Indiana | 46202 | — |
| Site 1052: Iowa Diabetes and Endocrinology Research Center | West Des Moines | Iowa | 50265 | — |
| Site 1054 Louisiana Research Center | Shreveport | Louisiana | 71105 | — |
| Site 1063 GI Alliance - Flowood | Flowood | Mississippi | 39232 | — |
| Site 1042: Lucas Research, Inc | Morehead City | North Carolina | 28557 | — |
| Site 1059: Premier Medical Group | Clarksville | Tennessee | 37040 | — |
| Site 1044: Quality Medical Research | Nashville | Tennessee | 37211 | — |
| Site 1005:Texas Clinical Research Institute, LLC | Arlington | Texas | 76012 | — |
| Site 1050: Pinnacle Clinical Research | Austin | Texas | 78757 | — |
| Site 1051: South Texas Research Institute | Edinburg | Texas | 78539 | — |
| Site 1043 Liver Specialists of Texas | Houston | Texas | 77030 | — |
| Site 1046 Houston Methodist Hospital | Houston | Texas | 77030 | — |
| Site 1039: Houston Research Institute | Houston | Texas | 77079 | — |
| Site 1003: Clinical Trials of Texas, LLC | San Antonio | Texas | 78215 | — |
| Site 1006: American Research Corporation | San Antonio | Texas | 78215 | — |
| Site 1056: Pinnacle Clinical Research | San Antonio | Texas | 78229 | — |
| Site 1053 Bon Secours Richmond Community Hospital LLC d/b/a Bon Secours Liver Institute of Richmond | Richmond | Virginia | 23236 | — |
| Site 1022 Liver Institute Northwest | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05415722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 12, 2025 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05415722 live on ClinicalTrials.gov.